Disgraced at Vertex, Ian Smith’s career implosion ends with swift exile from biotech boards
Ian Smith’s biopharma career went over a cliff on January 23rd when Vertex abruptly fired him for unexplained “personal behavior” the executive crew found unacceptable. Exile followed as his board seats quickly began to tumble after that.
Basic subscription required
Unlock this story instantly and join 54,900+ biopharma pros reading Endpoints daily — and it's free.